CompletedPhase 1ACTRN12609000236291

Randomised trial comparing controlled oxygen therapy with high-flow oxygen therapy in the treatment of patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in the pre-hospital setting

Sponsor

Associate Professor Richard Wood-Baker

Enrollment

150 participants

Start Date

Jul 1, 2006

Study Type

Interventional

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Summary

Purpose to determine if different oxygen therapies for patients having AECOPD in the pre-hospital setting have different outcomes (ie. Mortality, length of hospital stay, requirement for ventilation, difference ABGs)

Eligibility

Sex: Both males and femalesMin Age: 35 Yearss

Inclusion Criteria1

Confirmed Diagnosis COPD, acute respiratory symptoms, Transport and treatment by Tasmanian Ambulance Staff

Exclusion Criteria1

Asthma patients

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

controlled oxygen therapy to maintain oxygen saturations between 88-92% using nasal prongs and mask oxygen with nebulization of medication done by handheld air driven compressor for the duration of th